Skip to content

Professor Tony Magana Neurosurgery Blog

Sharing information for professionals and patients

Professor Tony Magana Neurosurgery Blog

Tag: chronic immune disorders

The immune response to SARS-CoV-2 can be life-saving or deadly

A Toll Like Receptor Type 3 may hold the key to treating COVID 19

A fundamental difference in the immunity of men and women is leading to research in how a difference in response of the immune system to SARS-CoV-2 can be life saving or deadly.

Even though women contract COVID 19 more often then men in part because women outnumber men in jobs like nursing, teaching, cleaning, etc. where there is frequent interaction with large groups or areas of people they do not seem to get as seriously sick or die as often. The same phenomena was seen with previous epidemics involving different coronaviruses then the current SARS-CoV-2.

Although at first differences in smoking or hygienic practices between the sexes were considered, the evidence did not confirm this hypothesis.

The male and female sex have significant differences in their immune systems relating to the X chromosome. Females have two X chromosomes while males have one X and one Y normally. On the X chromosome are a group of genes for Toll-Like Receptors (TLR). The TLR are located in organs which are very active in immune responses to fight infection including the spleen and white blood cells as well as those with exposure to contaminants outside the body including the lungs and gastrointestinal tract. Humans have ten different TLRs labeled TLR 1 to 10. Some of the TLR (TLR 2 and 5) are specifically sensitive to bacteria while TLR 3 and 4 may be sensitive to viral antigens.

Stimulation of TLRs can cause two reactions. For most except TLR3 one reaction results in the production of cytokines which are powerful inducers of inflammatory responses affecting multiple organs. Previous coronavirus epidemics and the the current COVID 19 have been seen in some patients to cause a cytokine storm syndrome (CSS). A cascade of reactions occurs leading to severe destructive inflammation affecting the lungs, heart, kidneys and even sometimes the brain to varying degrees. Organ failure, hemodynamic instability, and ultimately death can occur. The other reaction is to stimulate interferon beta which causes macrophages to engulf antigens (invaders or under some circumstance human ) and activates a form of T-Cells called Natural Killers.

SARS-CoV-2 can trigger a fatal cytokine storm

These reactions can be exaggerated causing damage to normal organs or early on may be protective. Research in mice in 2015 showed that stimulating TLR3 could create a protective response to a coronavirus.

Now getting back to the differences between the sexes. Women generally have two sets of TLRs in the body with two different gene types while men have one. Although most of the cells in the woman will randomly choose one set to be active which could be either gene this means in whole body some cells of each type will be present. Sometimes both chromosomes are working creating an approximately 15% higher level of TLR function than normal. It is suggested by some that having this situation at the time of infection may give women more protection then men as a group statistically.

The problem is that it is well known that women suffer more severely than men from chronic inflammatory conditions such as systemic lupus erythematosus. The interaction of TLRs with normal human tissues to which they become sensitized is being researched. Why do women not have a worse reaction leading to cytokine storm and more frequent death than men? Why do women do better? Could it be that having higher levels at the beginning and of two different types is important?

The controversial drug, hydroxychloroquine inhibits TLR4 response to lipopolysaccharide which in vitro studies suggest can inhibit the virus entering the membrane of the intended cell target. However when given to very sick patients resulted in worsening of lung function. Thus now it is being considered more for prophylaxis than treatment by some.

Some researchers have said that TLRS are “double edged swords” that can cure or kill. How TLRs responses are regulated and when in the course of disease these reactions are therapeutically manipulated may determine if these interventions are helpful or harmful. Research is needed how to better control them to treat COVID 19, autoimmune diseases, and even cancer.

Author Professor Tony MaganaPosted on April 21, 2020April 21, 2020Tags chronic immune disorders, COVID 19, cytokine storm, immune response, interferon, natural killers, research, SARS-Cov-2, T cells, Toll Like receptors, X chromosome controlled immunityLeave a comment on The immune response to SARS-CoV-2 can be life-saving or deadly
Tony Magana is Head and Professor in the Neurosurgery Department, School of Medicine, at Mekelle University College of Health Sciences involved in academic neurosurgery practice, teaching of residents, fellows and medical students, and research at the Ayder Comprehensive Specialized Hospital in Mekelle, Ethiopia. He is a part-time senior consultant in neurosurgery at Saint Gabriel General Hospital in Addis Ababa. Jointly appointed to serve as PhD Candidate Adviser and Faculty in Anatomy and Neuroscience in the Institute of Basic Sciences at the School Of Medicine, College of Health Sciences, Mekelle University. Professor Tony Magana also serves a developmental and educational consultant to industry, NGOs, and educational entities for EMG Consulting based in Addis Ababa, EThiopia

Links

Professor Tony Magana website is ethiopianeurosurgery.com You may contact Professor Tony Magana via his website contact page which gives his office locations and contact information. Find Professor Tony Magana on his Facebook Page. 

Archives

  • May 2020
  • April 2020
  • March 2020
  • January 2020
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • August 2018
  • July 2018
  • February 2017
  • October 2016

Recent Posts

  • A birth tragedy in Ethiopia with a moment of grace
  • The Path to Becoming a Neurosurgeon in Ethiopia
  • The immune response to SARS-CoV-2 can be life-saving or deadly
  • Polio ravaged New York in 1916
  • Hydroxychloroquine COVID 19: Misleading poor scientific diligence leads to questions

Recent Comments

  • Anwar M on COVID 19 To Bring a Medical Ethics Crisis to Ethiopia
  • Tim Teusink on Coronavirus: A Unique Dilemma for Ethiopia
  • Haylay on Coronavirus: A Unique Dilemma for Ethiopia
  • Getachew Hagos on Coronavirus: A Unique Dilemma for Ethiopia
  • Dr Abiodun I Okunlola on Head Injury Guideline for Northern Ethiopia from Mekelle University Neurosurgery Department

Professor Tony Magana, Head of Neurosurgery at Mekelle University in Ethiopia discusses neurosurgical issues

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Professor Tony Magana Neurosurgery Blog Proudly powered by WordPress